REXIPRA LS TAB

About

Rexipra LS tablets combine Escitalopram and Clonazepam, offering a dual-action approach to managing anxiety disorders and depression. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that works by increasing serotonin levels in the brain, thereby improving mood and reducing anxiety over time. Clonazepam is a benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, leading to immediate calming effects, muscle relaxation, and reduction of anxiety and panic attacks. This combination is particularly useful for patients who require rapid symptom relief while the antidepressant component takes effect. The synergistic action helps to alleviate both the acute and chronic aspects of anxiety and depressive disorders, providing comprehensive relief and improving patient well-being.

Uses

• Treatment of generalized anxiety disorder (GAD).
• Management of panic disorder with or without agoraphobia.
• Treatment of major depressive disorder with significant anxiety.
• Short-term relief of severe anxiety symptoms.

Directions For Use

Take Rexipra LS tablets orally, usually once daily, as prescribed by your doctor. Do not stop taking this medication abruptly without consulting your doctor.

Benefits

• Provides rapid relief from acute anxiety symptoms due to clonazepam.
• Offers long-term management of anxiety and depression with escitalopram.
• Synergistic action for comprehensive symptom control.
• Helps improve mood and reduce panic attacks.
• Reduces overall anxiety levels.
• Convenient fixed-dose combination.

Side Effects

• Drowsiness
• Dizziness
• Nausea
• Fatigue
• Insomnia
• Dry mouth
• Constipation
• Diarrhea
• Sexual dysfunction (escitalopram)
• Weight gain or loss
• Memory impairment (clonazepam)
• Withdrawal symptoms upon abrupt discontinuation

Safety Measures

• Alcohol - Absolutely avoid alcohol consumption. It significantly enhances the CNS depressant effects of clonazepam, leading to severe drowsiness, respiratory depression, coma, and potentially death.
• Pregnancy - Clonazepam is associated with an increased risk of congenital malformations, especially during the first trimester. Escitalopram may cause neonatal withdrawal symptoms. Use during pregnancy is generally not recommended; discuss risks with your doctor.
• Breastfeeding - Both escitalopram and clonazepam are excreted into breast milk. Monitor the infant for sedation, feeding difficulties, and withdrawal symptoms. Consult your doctor before breastfeeding.
• Liver - Both drugs are metabolized in the liver. Dose adjustment may be necessary for patients with hepatic impairment. Clonazepam is contraindicated in severe liver disease. Use with extreme caution.
• Kidney - Both drugs are primarily renally excreted. Dose adjustment may be necessary for patients with moderate to severe renal impairment. Monitor for adverse effects and drug accumulation.
• Lung - Clonazepam can cause respiratory depression, especially in patients with pre-existing respiratory conditions like COPD or sleep apnea. Use with extreme caution and monitor respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.